Fungi in Bronchiectasis: A Concise Review

Area of Science:

• Pulmonary Medicine
• Medical Mycology
• Microbiome Research

Background:

• Fungal infections are well-studied in immunosuppressed individuals, but their role in chronic lung diseases like bronchiectasis remains unclear.
• In bronchiectasis, impaired mucociliary clearance and thick mucus promote fungal spore persistence.
• Common fungi include Candida albicans and Aspergillus fumigatus, often co-occurring with bacteria like Haemophilus influenzae and Pseudomonas aeruginosa, complicating clinical significance assessment.

Purpose of the Study:

• To investigate the epidemiology, risk factors, and management of fungal infections in bronchiectasis.
• To explore the lung mycobiome in chronic pulmonary diseases.
• To understand the relationship between fungal diversity and lung function in bronchiectasis.

Main Methods:

• Analysis of the respiratory tract mycobiome using advanced techniques.
• Comparison of microbial diversity in patients with chronic respiratory diseases versus healthy individuals.
• Correlation analysis between fungal diversity and pulmonary function tests.

Main Results:

• Reduced fungal diversity was observed in most chronic respiratory diseases studied.
• Lower fungal diversity was found to correlate with poorer lung function.
• Conventional cultures often isolate prevalent fungi alongside bacterial pathogens, making clinical significance difficult to ascertain.

Conclusions:

• Understanding the lung mycobiome and its interactions with other microbiota is crucial for bronchiectasis pathogeny.
• Further research into fungal-bacterial interactions and mycobiome diversity can lead to innovative therapies.
• The study underscores the importance of investigating fungal presence and diversity in chronic lung conditions.